# Multi-omics Approach of Risk Stratification for Patients With de Novo Acute Myeloid Leukemia

> **NCT05983172** · — · ENROLLING_BY_INVITATION · sponsor: **National Taiwan University Hospital** · enrollment: 1500 (estimated)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05983172
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-08
- **Primary completion:** 2024-07
- **Final completion:** 2026-07
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2023-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05983172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05983172, "Multi-omics Approach of Risk Stratification for Patients With de Novo Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05983172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*